Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Virtus

Virtus KAR Mid-Cap Core Fund Class R6 (VRMCX)

Ticker VRMCX · Since 2018-01-30 · · Holdings as of Jun 30, 2026

Expense ratio
0.87%$87/yr per $10k
5-yr return
+5.6%annualized
1-yr return
+0.8%as of Dec 2025
Net assets
$1.8Ball share classes
Holdings
29

Bottom line

Is VRMCX a good fund? The bottom line

VRMCX is the Class R6 share class of Virtus KAR Mid-Cap Core Fund, a managed mid-cap mutual fund from Virtus.

Annual fees run 0.87% — about $87 a year on every $10,000 invested, cheaper than 50% of mid-cap funds we track.

It returned +0.8% over one year, +5.6% a year over five years (as of Dec 31, 2025, per its prospectus).

With $1.8 billion in net assets and 29 holdings, its largest position is Ametek Inc (6.7%) and the top 10 make up 48.2% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What VRMCX invests in

The fund has an investment objective of long-term capital appreciation.

The fund pursues long-term capital appreciation in the medium capitalization sector while seeking to provide the risk characteristics of the less volatile large capitalization S&P 500 Index. The fund invests in a select group of medium market capitalization companies believed by the subadviser to be undervalued relative to their future growth potential. The investment strategy emphasizes companies believed by the subadviser to have a sustainable competitive advantage, strong management and low financial risk and to be able to grow over market cycles. Although the fund invests primarily in U.S. companies, it may invest in foreign securities and depositary receipts. Under normal circumstances, the fund invests at least 80% of its assets in equity securities of medium market capitalization companies. As of the date of this Prospectus, the funds subadviser considers medium market…

From the fund's prospectus (filed Jan 22, 2026).

VRMCX performance

Average annual total returns
1 yr5 yr10 yr
VRMCX+0.8%+5.6%—
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full VRMCX performance history →

What VRMCX costs

On a $10,000 investment, VRMCX's 0.87% expense ratio costs about $87 a year. The prospectus estimates $1,138 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full VRMCX fee table →

VRMCX top 10 holdings

#Holding% of fund
1Ametek Inc AME6.69%
2Teledyne Technologies Inc TDY6.00%
3Westinghouse Air Brake Technologies Corp WAB5.79%
4West Pharmaceutical Services Inc WST5.33%
5Monolithic Power Systems Inc MPWR5.21%
6Ross Stores Inc ROST4.24%
7Heico Corp HEI/A4.20%
8Houlihan Lokey Inc HLI3.93%
9Advanced Drainage Systems Inc WMS3.53%
10Allegion Plc ALLE3.24%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 48.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to VRMCX

More funds like VRMCX →

VRMCX FAQ

What is the expense ratio of VRMCX?
VRMCX's expense ratio is 0.87%, which works out to about $87 a year for every $10,000 invested. The prospectus estimates total costs of $1,138 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VRMCX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does VRMCX hold?
VRMCX's largest holdings are Ametek Inc (6.7%), Teledyne Technologies Inc (6.0%), Westinghouse Air Brake Technologies Corp (5.8%), West Pharmaceutical Services Inc (5.3%), Monolithic Power Systems Inc (5.2%). It holds 29 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is VRMCX's 5-year return?
VRMCX returned +5.6% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does VRMCX have a sales load?
No. VRMCX has no front-end sales charge.
Who manages VRMCX?
VRMCX is offered by Virtus through Virtus Equity Trust.